Listartema Sanitari Integral d'Utilització Pública de Catalunya

A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

Vega, Pablo; Martinez-Raga, Jose; GRAU-LÓPEZ, LARA; AGUILAR, LOURDES; Torrens, Marta; Basurte-Villamor, Ignacio; Roncero, Carlos; Szerman, Nestor (Dove Medical Press, 2022-05-04)

Abstinence duration and psychopathology among addiction outpatients during 18 months of COVID-19

Daigre, Constanza; Sorribes, Marta; Ortega-Hernández, Germán; Perea-Ortueta, Marta; ROS-CUCURULL, ELENA; GRAU-LÓPEZ, LARA; Palma-Alvarez, Raul Felipe; Ramos-Quiroga, Josep Antoni (Frontiers Media, 2024-02-08)

Attention deficit hyperactivity disorder symptoms and cannabis use after 1 year among students of the i-Share cohort

Jean, Francois; Arsandaux, Julie; Montagni, Ilaria; Collet, Ophélie; Fatséas, Mélina; Auriacombe, Marc; Ramos-Quiroga, Josep Antoni (Cambridge University Press, 2022-03-29)

Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management

Grau Lopez, Lara; Marcos Fosch, Cristina; Daigre Blanco, Constanza; Palma Alvarez, Raul Felipe; Perea Ortueta, Marta; Rodríguez Frias, Francisco; Martinez Luna, Nieves Gudelia; Riveiro Barciela, Maria del Mar; Esteban Mur, Rafael; Rando Segura, Ariadna; Llaneras Artigues, Jordi; Buti Ferret, Maria; Ramos-Quiroga, Josep Antoni (SAGE Publications, 2021-01-01)

Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder

Szerman, Nestor; Vega, Pablo; Roncero, Carlos; Peris, Lola; GRAU-LÓPEZ, LARA; Basurte-Villamor, Ignacio (Wolters Kluwer Health, 2025-05)

Comparing nurses attending a specialised mental health programme with and without substance use disorder: a retrospective, observational study in Spain

Braquehais, María Dolores; Mozo, Xulián; Llavayol, Enric; Gausachs, Eva; Santiago, Regina; Nieva, Gemma; GRAU-LÓPEZ, LARA; Bruguera Cortada, Eugeni; Ramos-Quiroga, Josep Antoni (BMJ, 2024-04-05)

Consensus International sur le dépistage, le diagnostic et le traitement des patients avec troubles de l’usage de substances en cas de comorbidité avec un trouble du déficit de l’attention avec ou sans hyperactivité

van Kernebeek, Michiel; Vorspan, Florence; van den Brink, Wim; Dom, Geert; Moggi, Franz; van de Glindj, Geurt; Crunelle, Cleo; Ramos-Quiroga, Josep Antoni (Elsevier, 2022-06)

Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores

GRAU-LÓPEZ, LARA; Daigre, Constanza; Cabana-Dominguez, Judit; Soler Artigas, María; Alemany, Silvia; Llonga, Natalia; Vilar-Ribo, Laura; Arribas, Lorena; Ribases, Marta; Ramos-Quiroga, Josep Antoni (Springer Nature, 2024-05-29)

Gender differences in ADHD and impulsivity among alcohol or alcohol- and cocaine-dependent patients

Roncero , Carlos; Remón Gallo, Diego; García-Ullán, LLanyra; Vicente Hernández, Begoña; Buch Vicente, Barbara; GRAU-LÓPEZ, LARA; Palma-Alvarez, Raul Felipe (Frontiers Media, 2025-02-27)

Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders

Koller, Dora; Mitjans, Marina; Kouakou, Manuela; Friligkou, Eleni; Cabrera-Mendoza, Brenda; Deak, Joseph; Soler Artigas, María; Llonga, Natalia; Ribases, Marta; Ramos-Quiroga, Josep Antoni (Elsevier, 2024-03)

Management of schizophrenia and comorbid substance use disorders: expert review and guidance

Neyra, Adrián; Parro-Torres, Carlos; Carrera, Indalecio; Echarri, Eduardo; Torrens, Marta; ROS-CUCURULL, ELENA (BMC, 2024-10-30)

Multi-omics profiling of DNA methylation and gene expression alterations in human cocaine use disorder

Zillich, Eric; Belschner, Hanna; Avetyan, Diana; Andrade-Brito, Diego E.; Martínez Magaña, José Jaime; Frank, Josef; Cabana-Dominguez, Judit (Springer Nature, 2024-10-09)

Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study

Chacon Garcia, Fernando; Morano Amado, Luis Enrique; Granados, José Rafael; Llibre, Josep M; Ryan, Pablo; Navarro, Jordi (BMC, 2024-11-14)

Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus

Palma-Alvarez, Raul Felipe; Barta, Csaba; Carpentier, Pieter Jan; Carruthers, Susan; Crunelle, Cleo; Demetrovics, Zsolt; Ramos-Quiroga, Josep Antoni (Elsevier, 2023-01)

Scientia. Depósito de Información Digital del Departamento de Salud

ListarSistema Sanitari Integral d'Utilització Pública de Catalunya - SISCAT por tema "Abús de substàncies"

A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

Abstinence duration and psychopathology among addiction outpatients during 18 months of COVID-19

Attention deficit hyperactivity disorder symptoms and cannabis use after 1 year among students of the i-Share cohort

Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management

Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder

Comparing nurses attending a specialised mental health programme with and without substance use disorder: a retrospective, observational study in Spain

Consensus International sur le dépistage, le diagnostic et le traitement des patients avec troubles de l’usage de substances en cas de comorbidité avec un trouble du déficit de l’attention avec ou sans hyperactivité

Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores

Gender differences in ADHD and impulsivity among alcohol or alcohol- and cocaine-dependent patients

Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders

Management of schizophrenia and comorbid substance use disorders: expert review and guidance

Multi-omics profiling of DNA methylation and gene expression alterations in human cocaine use disorder

Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study

Sexualized drug injection among men who have sex with men in Madrid and Barcelona as the first episode of drug injecting

Sexualized drug use among men who have sex with men in Madrid and Barcelona: The gateway to new drug use?

Shared decision making in patients with substance use disorders: A one-year follow-up study

Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus

Scientia. Depósito de Información Digital del Departamento de Salud

ListarSistema Sanitari Integral d'Utilització Pública de Catalunya - SISCAT por tema "Abús de substàncies"

A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment ﻿

Abstinence duration and psychopathology among addiction outpatients during 18 months of COVID-19 ﻿

Attention deficit hyperactivity disorder symptoms and cannabis use after 1 year among students of the i-Share cohort ﻿

Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management ﻿

Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder ﻿

Comparing nurses attending a specialised mental health programme with and without substance use disorder: a retrospective, observational study in Spain ﻿

Consensus International sur le dépistage, le diagnostic et le traitement des patients avec troubles de l’usage de substances en cas de comorbidité avec un trouble du déficit de l’attention avec ou sans hyperactivité ﻿

Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores ﻿

Gender differences in ADHD and impulsivity among alcohol or alcohol- and cocaine-dependent patients ﻿

Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders ﻿

Management of schizophrenia and comorbid substance use disorders: expert review and guidance ﻿

Multi-omics profiling of DNA methylation and gene expression alterations in human cocaine use disorder ﻿

Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study ﻿

Sexualized drug injection among men who have sex with men in Madrid and Barcelona as the first episode of drug injecting ﻿

Sexualized drug use among men who have sex with men in Madrid and Barcelona: The gateway to new drug use? ﻿

Shared decision making in patients with substance use disorders: A one-year follow-up study ﻿

Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus ﻿

A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

Abstinence duration and psychopathology among addiction outpatients during 18 months of COVID-19

Attention deficit hyperactivity disorder symptoms and cannabis use after 1 year among students of the i-Share cohort

Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management

Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder

Comparing nurses attending a specialised mental health programme with and without substance use disorder: a retrospective, observational study in Spain

Consensus International sur le dépistage, le diagnostic et le traitement des patients avec troubles de l’usage de substances en cas de comorbidité avec un trouble du déficit de l’attention avec ou sans hyperactivité

Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores

Gender differences in ADHD and impulsivity among alcohol or alcohol- and cocaine-dependent patients

Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders

Management of schizophrenia and comorbid substance use disorders: expert review and guidance

Multi-omics profiling of DNA methylation and gene expression alterations in human cocaine use disorder

Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study

Sexualized drug injection among men who have sex with men in Madrid and Barcelona as the first episode of drug injecting

Sexualized drug use among men who have sex with men in Madrid and Barcelona: The gateway to new drug use?

Shared decision making in patients with substance use disorders: A one-year follow-up study

Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus